Analystreport

Castle Biosciences (CSTL) was upgraded by Zacks Research from "hold" to "strong-buy".

Castle Biosciences, Inc. - Common stock  (CSTL) 
Last castle biosciences, inc. - common stock earnings: 3/10 04:05 pm Check Earnings Report